worst decision by the fund manager IMO to buy back stock that doesn't have many outstanding shares.. IMO.
the reason for buy back was that the share price was trading below NTA with substantial discount so they are buying back to lift price which is foolish for stock with 39m outstanding shares... IMO.
- Forums
- ASX - By Stock
- Ann: Update - Notification of buy-back - CD1
CD1
cd private equity fund i
Add to My Watchlist
0.00%
!
53.5¢

worst decision by the fund manager IMO to buy back stock that...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
53.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.55M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8779 | 54.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
55.5¢ | 3548 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8779 | 0.545 |
1 | 2728 | 0.540 |
1 | 9992 | 0.535 |
1 | 36677 | 0.530 |
1 | 50000 | 0.525 |
Price($) | Vol. | No. |
---|---|---|
0.555 | 3548 | 1 |
0.560 | 8115 | 1 |
0.570 | 10000 | 1 |
0.585 | 1118 | 1 |
0.600 | 42500 | 2 |
Last trade - 11.00am 19/06/2025 (20 minute delay) ? |
Featured News
CD1 (ASX) Chart |
Day chart unavailable
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online